ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
1.036
0.014
(1.37%)
Closed July 02 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.036
Bid
1.032
Ask
1.04
Volume
4,675
1.02 Day's Range 1.04
1.00 52 Week Range 1.862
Market Cap
Previous Close
1.022
Open
1.04
Last Trade
69
@
1.036
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
46,543
Shares Outstanding
100,852,742
Dividend Yield
-
PE Ratio
-4.70
Earnings Per Share (EPS)
-0.22
Revenue
7.9M
Net Profit
-22.33M

About Transgene SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Illkirch-graffenstaden, Bas-rhin, Fra
Founded
1970
Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 1.02 €. Over the last year, Transgene shares have traded in a share price range of 1.00 € to 1.862 €.

Transgene currently has 100,852,742 shares outstanding. The market capitalization of Transgene is 104.89 € million. Transgene has a price to earnings ratio (PE ratio) of -4.70.

TNG Latest News

Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou

Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la...

Assemblée Générale Mixte de Transgene du 15 mai 2024

Assemblée Générale Mixte de Transgene du 15 mai 2024 Strasbourg, France, le 15 mai 2024, 17 h 45 – L’Assemblée Générale Mixte (ordinaire et extraordinaire) des actionnaires de Transgene a eu...

Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024

Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024 TG4050 : Données prometteuses de Phase I présentées à l'AACR 2024 démontrant les premiers signes...

Transgene provides business and financial update for Q1 2024

TG4050: Exciting Phase I data presented at AACR 2024 demonstrating first signs of clinical benefit in adjuvant setting for head and neck cancer  Phase II part of randomized trial to start in...

Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai 2024

Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai 2024 Strasbourg, France – Le 24 avril 2024, 17 h 45 – Transgene (Euronext Paris : TNG), société de...

Document d'enregistrement Universel 2023

Document d'enregistrement Universel 2023 Document d'enregistrement Universel 2023 Pièces jointes DEU Transgene 2023-FR 969500PDJW8N0FSGGK69-2023-12-31-fr

MIse à disposition du document d'enregistrement universel 2023 de Transgene

MIse à disposition du document d'enregistrement universel 2023 de Transgene TRANSGENE (Paris : TNG) annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des...

Availability of Transgene's 2023 Universal Registration Document

Availability of Transgene's 2023 Universal Registration Document TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31...

Transgene et NEC présentent les premiers signes de bénéfice clinique de leur vaccin individualisé contre le cancer, TG4050, dans les cancers de la tête et du cou à l’AACR 2024

Transgene et NEC présentent les premiers signes de bénéfice clinique de leur vaccin individualisé contre le cancer, TG4050, dans les cancers de la tête et du cou à l’AACR 2024 Les nouvelles...

Transgene prévoit des avancées significatives sur son portefeuille d’immunothérapies en 2024 et étend sa visibilité financière jusqu’au 4ème trimestre 2025

Transgene prévoit des avancées significatives sur son portefeuille d’immunothérapies en 2024 et étend sa visibilité financière jusqu’au 4ème trimestre 2025 Résultats annuels 2023 et point sur...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.074-6.666666666671.111.1181.004272871.06128302DE
4-0.28-21.27659574471.3161.3241333261.12743819DE
12-0.154-12.94117647061.191.521465431.29205941DE
26-0.346-25.03617945011.3821.521318891.25919642DE
52-0.796-43.44978165941.8321.8621284381.41237121DE
156-1.289-55.44086021512.3252.991433262.11589783DE
260-1.404-57.54098360662.443.150.81765782.012784DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDZNRoadzen Inc
$ 2.95
(82.10%)
107.99M
SYTSYLA Technologies Company Ltd
$ 3.05
(59.69%)
6.19M
VSVersus Systems Inc
$ 1.90
(43.94%)
58.92M
VIVKVivakor Inc
$ 3.41
(36.95%)
727.57k
MEDSTRxADE HEALTH Inc
$ 18.585
(30.70%)
397.65k
MAXNMaxeon Solar Technologies Ltd
$ 0.18
(-67.20%)
173.82M
RNACCartesian Therapeutics Inc
$ 15.7715
(-35.02%)
1.45M
EFTReFFECTOR Therapeutics Inc
$ 0.18
(-32.56%)
1.63M
DTSSDatasea Inc
$ 3.43
(-30.57%)
1.15M
ARDXArdelyx Inc
$ 5.29
(-30.12%)
22.67M
NVDANVIDIA Corporation
$ 122.67
(-1.31%)
220.35M
TSLATesla Inc
$ 231.26
(10.20%)
205.03M
MAXNMaxeon Solar Technologies Ltd
$ 0.18
(-67.20%)
173.82M
SQQQProShares UltraPro Short QQQ
$ 7.88
(-2.96%)
114.55M
RDZNRoadzen Inc
$ 2.95
(82.10%)
107.99M

Discussion

View Full Feed
bigstocksnbonds bigstocksnbonds 3 minutes ago
I KNOW YOU WILL GET THERE!!!

Even though the process is Slow indeed!!!!

You will get there!!!!!!
crazy horse 0 crazy horse 0 4 minutes ago
Over 200 French election candidates quit in effort to block hard-Right

https://mol.im/a/13594307
Zlakr Zlakr 4 minutes ago
Money never sleeps. Haha. All fuking around aside, where do you think it's headed tomorrow? I'm curious about your take.
SMCE
Value_Investor Value_Investor 5 minutes ago
Welcome to the board, new AFFL investor! With Very Strong Slapping Actions Again tomorrow, another New 52-week-high $0.04 will be created...

Anyway, buying its OTC peer (FCCN) at today's high $3.02 = buying AFFL at $7.7139 which is 214.3 Times of Super-Ridiculous-Low today's h
AFFL FCCN
m_m007 m_m007 5 minutes ago
You have a point. It’s over bought. It might test high tomorrow or it may not. Holding my 0009-0013 not going anywhere
SMCE
MightyX MightyX 5 minutes ago
TPT’s medical division much-alive(countering traders false-claims):“We are currently able to deliver a live Global Mobile TV Broadcast and Social Media Platform utilizing a Mobile App technology on our proprietary Content Delivery Network “VuMe”. We plan to expand our Cloud Unified Business Services
TPTW
prototype_101 prototype_101 5 minutes ago
Lebby gave a Keynote at OFC 2024 about "Heterogeneous Integration", here AMAT speaks about heterogeneous integration as well as saying that "materials science and materials engineering are increasingly important to the industry's road map", AMAT has been discussed here many times as a Tier 1 very li
LWLG
prototype_101 prototype_101 6 minutes ago
ECOC Market Focus Topics!! Polymers RULE!! Check it out!!!

September 23-25, 2024

Components/ICs/PICs/fiber
1. Classic component performance (discrete and
integrated photonics), ROADMs
2. High speed, low power modulators (polymer, TFLN,
plas
LWLG
Kmacneill116 Kmacneill116 7 minutes ago
Going to go boom at some point mms will let it ride $$$
RNVA
arizona1 arizona1 7 minutes ago
She owes trump the money. It's terrifying what he does to people who cross him. She's about to lose everything.
prototype_101 prototype_101 8 minutes ago
Infinera: Optics is Everywhere in the AI Era

Interview from OFC 2024, Heavy Reading analyst Sterling Perrin and Infinera CEO David Heard discuss how the AI traffic boom will drive optics in data center interconnect, subsea and terrestrial telecom networks, and also open new opportunit
ASM LWLG
want2retire want2retire 9 minutes ago
“We have to wait until the third wave to see a big boost in production.”

Agreed. What is happening now is laying the groundwork for the production boost to happen.

Silk production is not the focus right now. Building up the colonies so much larger (and presumably stag
KBLB
getmoreshares getmoreshares 9 minutes ago
much lower vol-- like many positions this week- Markets closed thurs.
ICTY
arizona1 arizona1 11 minutes ago
Why should we be worried about Project 2025?

Because B4 is too stupid to know how badly it's going to affect him and his grandchildren. He should be prepared to become a great grandfather as soon as birth control is deemed illegal.
DewmBoom DewmBoom 11 minutes ago
We are overdue on the NASDAQ extension update. Hopefully this week or next week!
COSM
janice shell janice shell 11 minutes ago
Which convicted felon/rapist? Trumpty or Avenatti? Though far as I know, Avenatti's never raped anyone. Why would she owe anyone that much?
DewmBoom DewmBoom 12 minutes ago
More good news was published later today

https://x.com/dewmboom/status/1808239710923358242?s=46&t=4i2e71_mIJlM2gX3MyKXew
COSM
getmoreshares getmoreshares 13 minutes ago
an update will send both higher!
STAL
toncatmad toncatmad 13 minutes ago
Do you really feel it’s telling that we correct the lies being told that good things could be coming ? Seriously? If you feel it’s telling that I am posting then you should stop trading because that’s crazy
Evaluate Evaluate 14 minutes ago
Haha - good one! Yup: "it's me". Still got a bit of a NWBO investment ... nothing significant, but I did add a bit more after listening to Linda Powers at ASM.
ASM NWBO
arizona1 arizona1 14 minutes ago
Yeah, it was really a tearjerker. She owes the convicted felon/rapist over $600,000 dollars. Try to watch the rerun, it's so sad.
Dr Blunt Dr Blunt 14 minutes ago
0.000001 0.00 (0.00%) Volume: 4,900
$MSTO
Masterbeat Corporation

Day Range: 0.000001 - 0.000001
Last Trade Time: 11:23:58 AM EDT
MSTO
fuagf fuagf 15 minutes ago
Karen and Ken. They sure are. As per i tossed in an edit back there.
blackhawks blackhawks 15 minutes ago
I can accept that Biden is 'having trouble' and also credibly argue that Trump is a convicted felon prone to way too many really stupid f'ing riffs that call his own cognition into question. Watch and TRY and learn.

Also he IS on the wrong side of the issues that concern women voters,
toncatmad toncatmad 15 minutes ago
I agree we all have our faults and can all be stupid and do stupid things 100%!
That has nothing to do with FKA BioAmber though. One side is dead wrong (anyone who feels there is more to come here) the other side is 100% correct (those of us pointing out the facts that FKA BioAmber has ZERO

Your Recent History

Delayed Upgrade Clock